Could host response guide VAP treatment? No answer yet – Authors' reply
- 1 May 2020
- journal article
- letter
- Published by Elsevier BV in The Lancet. Respiratory Medicine
- Vol. 8 (5), e38-E38
- https://doi.org/10.1016/s2213-2600(20)30133-8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThe Lancet Respiratory Medicine, 2020
- The Role of Bronchoscopic Findings and Bronchoalveolar Lavage Fluid Cytology in Early Diagnosis of Ventilator-Associated PneumoniaRespiratory Care, 2016
- Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumoniaThorax, 2014
- Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort studyThe Lancet Infectious Diseases, 2011
- Diagnostic importance of pulmonary interleukin-1 and interleukin-8 in ventilator-associated pneumoniaThorax, 2009